視神経脊髄炎(デビック病)治療のグローバル臨床試験動向（2014年下半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Neuromyelitis Optica (Devic’s Syndrome) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Neuromyelitis Optica (Devic’s Syndrome) to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Neuromyelitis Optica (Devic’s Syndrome) to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Neuromyelitis Optica (Devic’s Syndrome) Therapeutics Clinical Trials 28
Prominent Drugs 30
Latest Clinical Trials News on Neuromyelitis Optica (Devic’s Syndrome) 31
Apr 24, 2014: Alexion Initiates Multinational Registration Trials of Eculizumab as a Potential Treatment for Patients with Relapsing Neuromyelitis Optica and Refractory Generalized Myasthenia Gravis 31
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Alexion Pharmaceuticals, Inc. 33
Clinical Trial Overview of Alexion Pharmaceuticals, Inc. 33
Shire Plc 34
Clinical Trial Overview of Shire Plc 34
F. Hoffmann-La Roche Ltd. 35
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35
Takeda Pharmaceutical Company Limited 36
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 36
Shenzhen Beike Biotechnology Co., Ltd. 37
Clinical Trial Overview of Shenzhen Beike Biotechnology Co., Ltd. 37
Bionure Farma, S.L. 38
Clinical Trial Overview of Bionure Farma, S.L. 38
Alnylam Pharmaceuticals, Inc. 39
Clinical Trial Overview of Alnylam Pharmaceuticals, Inc. 39
Clinical Trial Overview of Top Institutes / Government 40
Johns Hopkins University 40
Clinical Trial Overview of Johns Hopkins University 40
Mayo Clinic 41
Clinical Trial Overview of Mayo Clinic 41
National Neuroscience Institute 42
Clinical Trial Overview of National Neuroscience Institute 42
University of California, San Francisco 43
Clinical Trial Overview of University of California, San Francisco 43
University of Texas Southwestern Medical Center at Dallas 44
Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 44
State University of New York at Buffalo 45
Clinical Trial Overview of State University of New York at Buffalo 45
Kobe University 46
Clinical Trial Overview of Kobe University 46
Northwestern University 47
Clinical Trial Overview of Northwestern University 47
Sun Yat-sen University 48
Clinical Trial Overview of Sun Yat-sen University 48
National Institute of Neurological Disorders and Stroke 49
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 49
Five Key Clinical Profiles 50
Appendix 132
Abbreviations 132
Definitions 132
Research Methodology 133
Secondary Research 133
About GlobalData 134
Contact Us 134
Disclaimer 134
Source 134